Learn more about our parent company “Yuhan Corporation by watching this video.
Yuhan gets USD 30 Million from J&J as Lazcluze-Rybrevant reaches Europe
Yuhan Corporation announced that it will receive a $30 million milestone payment from Johnson & Johnson following the European commercial launch of lazertinib (Korean brand